Lancet study says Sputnik V vaccine 91.6% effective
Updated / Tuesday, 2 Feb 2021 17:25 Sputnik V was approved before late stage trial results were published Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, according to results published today that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out. Sputnik V, named after the Soviet-era satellite, was approved in Russia months before results from its final-stage clinical trials were published, leading to scepticism from experts. But the new analysis of data from 20,000 Phase 3 trail participants, published in T...